NCT02828046View on ClinicalTrials.gov

An Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 9, 2016

Primary Completion Date

August 8, 2017

Study Completion Date

August 8, 2017

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

M281

OTHER

Placebo

Trial Locations (1)

Unknown

PRA Health Sciences, Zuidlaren

Sponsors
All Listed Sponsors
lead

Momenta Pharmaceuticals, Inc.

INDUSTRY

NCT02828046 - An Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) | Biotech Hunter | Biotech Hunter